In one paragraphArticle in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Jorge-Eduardo Ponce-ZeaResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0002-9058-7727 Byeol RyuResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0002-3405-2875 Ju-Yong LeeResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Eun-Jin ParkResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Van-Hieu MaiResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.
Thi-Phuong DoanResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0001-8662-1251 Hee-Ju LeeNatural Product Informatics Research Center, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea.
Won-Keun OhResearch Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.ORCID 0000-0003-0761-3064 Funding
Basic Science Research Program through the National Research Foundation of Korea (N.R.F.) funded by the Ministry of Science and I.C.T. in Korea 2022M3H9A108298421Basic Science Research Program through the National Research Foundation of Korea (N.R.F.) funded by the Ministry of Science and I.C.T. in Korea NRF-2022R1A2C200506113
6 · The paper itselfAbstract
As part of our ongoing research on new anti-diabetic compounds from ethnopharmacologically consumed plants, two previously undescribed lupane-type triterpenoids (
Indexed as
Enzyme InhibitorsGlucoseMyrtaceaeProtein Tyrosine Phosphatase, Non-Receptor Type 1AdipocytesAnimalsCell LineComputer SimulationMiceMolecular Docking SimulationPlant LeavesStructure-Activity RelationshipEnzyme InhibitorsGlucoseProtein Tyrosine Phosphatase, Non-Receptor Type 1Ptpn1 protein, mouseCleistocalyx operculatusglucose uptakekineticmolecular dockingMyrtaceaeprotein tyrosine phosphatase 1B (PTP1B)
Identifiers
PMID39275157
PMCPMC11397035
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390